These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
161 related items for PubMed ID: 14984501
1. The use of a national transplant registry to benchmark transplant outcome for patients undergoing autologous and allogeneic stem cell transplantation in the United Kingdom and Ireland. Russell NH, Szydlo R, McCann S, Potter MN, Craddock C, Towlson K, Apperley JF, British Society for Blood and Marrow Transplantation. Br J Haematol; 2004 Feb; 124(4):499-503. PubMed ID: 14984501 [Abstract] [Full Text] [Related]
2. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation. Peniket AJ, Ruiz de Elvira MC, Taghipour G, Cordonnier C, Gluckman E, de Witte T, Santini G, Blaise D, Greinix H, Ferrant A, Cornelissen J, Schmitz N, Goldstone AH, European Bone Marrow Transplantation (EBMT) Lymphoma Registry. Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607 [Abstract] [Full Text] [Related]
3. Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease. European Group for Blood and Bone Marrow Transplantation. Milpied N, Fielding AK, Pearce RM, Ernst P, Goldstone AH. J Clin Oncol; 1996 Apr; 14(4):1291-6. PubMed ID: 8648386 [Abstract] [Full Text] [Related]
4. Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Majolino I, Pearce R, Taghipour G, Goldstone AH. J Clin Oncol; 1997 Feb; 15(2):509-17. PubMed ID: 9053472 [Abstract] [Full Text] [Related]
5. Validation and extension of the EBMT Risk Score for patients with chronic myeloid leukaemia (CML) receiving allogeneic haematopoietic stem cell transplants. Passweg JR, Walker I, Sobocinski KA, Klein JP, Horowitz MM, Giralt SA, Chronic Leukemia Study Writing Committee of the International Bone Marrow Transplant Registry. Br J Haematol; 2004 Jun; 125(5):613-20. PubMed ID: 15147377 [Abstract] [Full Text] [Related]
6. Allogeneic stem cell transplantation in patients with atypical chronic myeloid leukaemia: a retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation. Onida F, de Wreede LC, van Biezen A, Eikema DJ, Byrne JL, Iori AP, Schots R, Jungova A, Schetelig J, Finke J, Veelken H, Johansson JE, Craddock C, Stelljes M, Theobald M, Holler E, Schanz U, Schaap N, Bittenbring J, Olavarria E, Chalandon Y, Kröger N. Br J Haematol; 2017 Jun; 177(5):759-765. PubMed ID: 28369779 [Abstract] [Full Text] [Related]
7. Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China. Liu QF, Xu XJ, Chen YK, Sun J, Zhang Y, Fan ZP, Xu D, Jiang QL, Wei YQ, Huang F, Feng R, Liu XL, Xu B, Meng FY. Ann Hematol; 2011 Mar; 90(3):331-41. PubMed ID: 20872002 [Abstract] [Full Text] [Related]
8. Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation--The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Bierman PJ, Sweetenham JW, Loberiza FR, Taghipour G, Lazarus HM, Rizzo JD, Schmitz N, van Besien K, Vose JM, Horowitz M, Goldstone A, Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. J Clin Oncol; 2003 Oct 15; 21(20):3744-53. PubMed ID: 12963703 [Abstract] [Full Text] [Related]
9. Haemopoietic stem cell transplantation in Australia, 1992-95: a report from the Australian Bone Marrow Transplant Recipient Registry. Atkinson K, Nivison-Smith I, Hawkins T. Aust N Z J Med; 1997 Aug 15; 27(4):408-19. PubMed ID: 9448882 [Abstract] [Full Text] [Related]
10. Autotransplants for Hodgkin's disease in first relapse or second remission: a report from the autologous blood and marrow transplant registry (ABMTR). Lazarus HM, Loberiza FR, Zhang MJ, Armitage JO, Ballen KK, Bashey A, Bolwell BJ, Burns LJ, Freytes CO, Gale RP, Gibson J, Herzig RH, LeMaistre CF, Marks D, Mason J, Miller AM, Milone GA, Pavlovsky S, Reece DE, Rizzo JD, van Besien K, Vose JM, Horowitz MM. Bone Marrow Transplant; 2001 Feb 15; 27(4):387-96. PubMed ID: 11313668 [Abstract] [Full Text] [Related]
11. Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: progress report from the Australasian Bone Marrow Transplant Recipient Registry. Nivison-Smith I, Bradstock KF, Dodds AJ, Hawkins PA, Szer J. Intern Med J; 2005 Jan 15; 35(1):18-27. PubMed ID: 15667464 [Abstract] [Full Text] [Related]
12. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT). Gorin NC, Labopin M, Fouillard L, Meloni G, Frassoni F, Iriondo A, Brunet Mauri S, Goldstone AH, Harousseau JL, Reiffers J, Esperou-Bourdeau H, Gluckman E. Bone Marrow Transplant; 1996 Jul 15; 18(1):111-7. PubMed ID: 8832003 [Abstract] [Full Text] [Related]
14. Report from the International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry - North America. Passweg JR, Rowlings PA, Armitage JO, Gale RP, Pelz CJ, Sobocinski KA, Klein JP, Zhang MJ, Horowitz MM. Clin Transpl; 1995 Jul 15; ():117-27. PubMed ID: 8794259 [Abstract] [Full Text] [Related]
15. Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome. De Souza CA, Vigorito AC, Ruiz MA, Nucci M, Dulley FL, Funcke V, Tabak D, Azevedo AM, Byington R, Macedo MC, Saboya R, Penteado Aranha FJ, Oliveira GB, Zulli R, Martins Miranda EC, Azevedo WM, Lodi FM, Voltarelli JC, Simões BP, Colturato V, De Souza MP, Silla L, Bittencourt H, Piron-Ruiz L, Maiolino A, Gratwohl A, Pasquini R. Haematologica; 2005 Feb 15; 90(2):232-7. PubMed ID: 15710577 [Abstract] [Full Text] [Related]
16. Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT). Gratwohl A, Passweg J, Baldomero H, Hermans J. Bone Marrow Transplant; 1999 Aug 15; 24(3):231-45. PubMed ID: 10456992 [Abstract] [Full Text] [Related]
20. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT). Aoudjhane M, Labopin M, Gorin NC, Shimoni A, Ruutu T, Kolb HJ, Frassoni F, Boiron JM, Yin JL, Finke J, Shouten H, Blaise D, Falda M, Fauser AA, Esteve J, Polge E, Slavin S, Niederwieser D, Nagler A, Rocha V, Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT). Leukemia; 2005 Dec 15; 19(12):2304-12. PubMed ID: 16193083 [Abstract] [Full Text] [Related] Page: [Next] [New Search]